Related Experiment Videos
Interleukin-18 promoter polymorphisms in type 1 diabetes.
Adam Kretowski1, Katarzyna Mironczuk, Anna Karpinska
1Department of Endocrinology, Diabetology and Internal Medicine, Academy of Bialystok, Bialystok, Poland. akretows@amb.ac.bialystok.pl
Diabetes
|October 29, 2002
Summary
Genetic variations in the interleukin-18 (IL-18) gene promoter are associated with type 1 diabetes. Specific IL-18 promoter genotypes, particularly at position -137, show a significant difference between type 1 diabetes patients and healthy individuals.
Area of Science:
- Immunology
- Genetics
- Endocrinology
Background:
- Type 1 diabetes is an autoimmune disease involving Th1 lymphocytes.
- Interleukin-18 (IL-18) is a pro-inflammatory cytokine that promotes Th1 responses.
- Elevated IL-18 levels have been observed in early stages of type 1 diabetes.
Purpose of the Study:
- To investigate the association between IL-18 gene promoter polymorphisms and type 1 diabetes.
- To compare the frequency of specific IL-18 promoter polymorphisms in type 1 diabetes patients versus healthy controls.
Main Methods:
- Analysis of two single-nucleotide polymorphisms (-137 and -607) in the IL-18 promoter region.
- Genotyping of patients with type 1 diabetes and healthy control subjects.
- Statistical comparison of genotype distributions between the groups.
Main Results:
- Significant differences in genotype distribution were observed between type 1 diabetes patients and controls.
- An increased frequency of GC genotypes at position -137 and a decreased frequency of GG genotypes were noted in patients.
- The AA genotype at position -607 was exclusively found in the control group.
Conclusions:
- The study provides the first evidence linking polymorphisms in the IL-18 promoter gene to type 1 diabetes susceptibility.
- The contribution of -137GC genotypes to genetic susceptibility is influenced by IL-18 promoter haplotypes.